WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Aug 15, 2025, 12:21 PM
3.90
-2.50%
After-hours: Aug 13, 2025, 08:00 PM EDT

WuXi Biologics (Cayman) Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
4.83B 3.4B 5.36B 3.99B
Depreciation & Amortization
1.44B 1.17B 800.67M 481.78M
Stock-Based Compensation
1.22B 1.27B 1.3B 577.95M
Other Working Capital
-1.16B -301.13M -476.35M -180.14M
Other Non-Cash Items
-1.47B -279.1M -876.68M -45.13M
Deferred Income Tax
n/a n/a n/a -567.11M
Change in Working Capital
-800.5M -896.35M -974.47M -963.33M
Operating Cash Flow
5.22B 4.67B 5.54B 3.43B
Capital Expenditures
-3.93B -4.23B -5.87B -6.52B
Cash Acquisitions
n/a n/a -131.49M -2.54B
Purchase of Investments
-11.43B -15.08B -10.77B -59.3B
Sales Maturities Of Investments
10.89B 15.64B 10.49B 58.24B
Other Investing Acitivies
524.28M 261.99M 377.56M 512.79M
Investing Cash Flow
-3.94B -3.23B -5.91B -9.6B
Debt Repayment
490.1M -818.45M -295.02M -146.83M
Common Stock Repurchased
-1.77B -916.92M -2.8B -2.52B
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1.49B 3.7B 507.88M -161.91M
Financial Cash Flow
-2.75B 1.96B -2.59B 8.21B
Net Cash Flow
-1.39B 3.27B -2.61B 1.91B
Free Cash Flow
1.29B 437.2M -326.72M -3.09B